TIDMVRP
LONDON and RALEIGH, N.C., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Verona
Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma" or the "Company"), a
clinical-stage biopharmaceutical company focused on respiratory diseases,
announces that, on August 20, 2020 it granted 6,794,521 Restricted
American Depositary Share Units ("RADSUs"), representing 54,356,168
ordinary shares of 5 pence each ("Ordinary Shares"), to directors and
employees of Verona Pharma under and in accordance with Verona Pharma's
2017 Incentive Award Plan (the "Incentive Plan"). In aggregate these
RADSU awards are over shares representing 13.11% of the total voting
rights in the Company's current issued share capital (the "TVR").
Details of the Incentive Plan are contained in the Company's 2019 Annual
Report and 20-F SEC filing, both of which are available on the
"Investors" section of the Company's website (
https://www.globenewswire.com/Tracker?data=Orx4LEDMwvmREQIfBDkLE4dAfxehudryHshGZ6_YZ9qJtSOsN7Qck90D2ARMeLozOWaSbFbeUVlnhTXfkgag2fvjFv9FYYhW3RBjPqdaPZMVDhKOsroxDmohAJPDd28DNOXmVzBd39xz-qCwgxwWH0cfeGFif-wWOzDng3PeaGbVwicpeActrHw1e-o4pu2z
https://www.veronapharma.com/investors/news-sec-filings). Additional
authority to issue new shares arising from the exercise of options or
RADSUs was granted by shareholders at the Company's most recent annual
general meeting held on April 16, 2020.
Each RADSU represents an unfunded, unsecured right to receive, on the
applicable settlement date, one American Depositary Share ("ADS"), or an
amount in cash or other consideration.
Grants to PDMRs
Of the RADSUs granted, the following grants were made to persons
discharging managerial responsibilities ("PDMRs"):
-- 14,500 RADSUs, representing 116,000 Ordinary Shares or 0.03% of the TVR,
were granted to each non-executive director of the Company. The RADSUs
granted to the non-executive directors will vest 50% at November 1, 2020,
25% at February 1, 2021 and the remaining 25% at May 1, 2021.
-- 1,785,203 RADSUs, representing 14,281,624 Ordinary Shares, were granted
to Dr David Zaccardelli, CEO, and 1,916,861 RADSUs, representing
15,334,888 Ordinary Shares, were granted to Mr Mark Hahn, CFO, pursuant
to their employment agreements, as detailed in the Company's 2019 20-F
SEC filing. Following the grants, Dr Zaccardelli will hold 2,356,386
RADSUs, representing 18,851,088 Ordinary Shares or 4.55% of the TVR, and
Mr Hahn will hold 2,334,111 RADSUs, representing 18,672,888 Ordinary
Shares, or 4.50% of the TVR. The newly granted RADSUs will vest as to 25%
on February 1, 2021, being the first anniversary of commencement of Dr
Zaccardelli's and Mr Hahn's employment, and the balance over the
remaining three years in twelve equal instalments upon completion of each
successive three-month period of continued employment by the relevant
executive.
-- 383,395 RADSUs, representing 3,067,160 Ordinary Shares or 0.74% of the
TVR, were granted to Dr Kathleen Rickard, CMO, and 340,000 RADSUs,
representing 2,720,000 Ordinary Shares or 0.66% of the TVR, were granted
to Claire Poll, General Counsel. These RADSUs will vest as to 25% on
August 1, 2021, and the balance over the remaining three years in twelve
equal instalments upon completion of each successive three-month period
of continued employment by the relevant executive.
The notification of dealing form in respect of RADSU awards for each
PDMR can be found below.
Grants to employees
Additional RADSU grants were made to certain employees over a total of
2,253,062 ADSs, representing 18,024,496 Ordinary Shares, or 4.35% of the
TVR. The vesting of these RADSUs is on the same basis as for the RADSUs
granted to Dr Rickard and Mrs Poll described above.
For further information, please contact:
Verona Pharma plc Tel: +44 (0)20 3283 4200
David Zaccardelli, Chief Executive Officer info@veronapharma.com
Victoria Stewart, Director of Communications
N+1 Singer Tel: +44 (0)20 7496 3000
(Nominated Adviser and UK Broker)
Aubrey Powell / George Tzimas / Iqra Amin
1 Details of the person discharging managerial responsibilities
/ person closely associated
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Dr David Ebsworth
----------------------------------------------------------- ---------------------------------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Chairman
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ---------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ---------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
----------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- ---------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- ----------------------------------------------------
No consideration paid 14,500 RADSUs (representing 116,000 Ordinary Shares)
----------------------------------------------------------- --------------------- ----------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ---------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ---------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ---------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------------------------------------------------------------------------------
a) Name Dr David Zaccardelli
----------------------------------------------------------- -------------------------------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Chief Executive Officer
----------------------------------------------------------- -------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- -------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
--------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- -------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- --------------------------------------------------
No consideration paid 1,785,203 RADSUs (representing 14,281,624 Ordinary
Shares)
----------------------------------------------------------- --------------------- --------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- -------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- -------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- -------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Dr Ken Cunningham
----------------------------------------------------------- ---------------------------------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ---------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ---------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
----------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- ---------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- ----------------------------------------------------
No consideration paid 14,500 RADSUs (representing 116,000 Ordinary Shares)
----------------------------------------------------------- --------------------- ----------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ---------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ---------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ---------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Dr Martin Edwards
----------------------------------------------------------- ---------------------------------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ---------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ---------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
----------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- ---------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- ----------------------------------------------------
No consideration paid 14,500 RADSUs (representing 116,000 Ordinary Shares)
----------------------------------------------------------- --------------------- ----------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ---------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ---------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ---------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Mr Rishi Gupta
----------------------------------------------------------- ---------------------------------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ---------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ---------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
----------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- ---------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- ----------------------------------------------------
No consideration paid 14,500 RADSUs (representing 116,000 Ordinary Shares)
----------------------------------------------------------- --------------------- ----------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ---------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ---------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ---------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Dr Mahendra Shah
----------------------------------------------------------- ---------------------------------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ---------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ---------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
----------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- ---------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- ----------------------------------------------------
No consideration paid 14,500 RADSUs (representing 116,000 Ordinary Shares)
----------------------------------------------------------- --------------------- ----------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ---------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ---------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ---------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Dr Andrew Sinclair
----------------------------------------------------------- ---------------------------------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ---------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ---------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
----------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- ---------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- ----------------------------------------------------
No consideration paid 14,500 RADSUs (representing 116,000 Ordinary Shares)
----------------------------------------------------------- --------------------- ----------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ---------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ---------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ---------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Mr Vikas Sinha
----------------------------------------------------------- ---------------------------------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ---------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ---------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
----------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- ---------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- ----------------------------------------------------
No consideration paid 14,500 RADSUs (representing 116,000 Ordinary Shares)
----------------------------------------------------------- --------------------- ----------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ---------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ---------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ---------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Dr Anders Ullman
----------------------------------------------------------- ---------------------------------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ---------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ---------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
----------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ---------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs
----------------------------------------------------------- ---------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- ----------------------------------------------------
No consideration paid 14,500 RADSUs (representing 116,000 Ordinary Shares)
----------------------------------------------------------- --------------------- ----------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ---------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ---------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ---------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------------------------------------------------------------------------------
a) Name Mark Hahn
----------------------------------------------------------- -------------------------------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Chief Financial Officer
----------------------------------------------------------- -------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- -------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
--------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- -------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs, each of which represents an unfunded,
unsecured right to receive, on the applicable settlement
date, one ADS or an amount in cash or other consideration.
----------------------------------------------------------- -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- --------------------------------------------------
No consideration paid 1,916,861 RADSUs (representing 15,334,888 Ordinary
Shares)
----------------------------------------------------------- --------------------- --------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- -------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- -------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- -------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
-------------------------------------------------------------------------------------------------------------------------------------------
a) Name Claire Poll
----------------------------------------------------------- ------------------------------------------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------------------------------------------------------
a) Position/status General Counsel
----------------------------------------------------------- ------------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ------------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ------------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ------------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-------------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ------------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs, each of which represents an unfunded,
unsecured right to receive, on the applicable settlement
date, one ADS or an amount in cash or other consideration.
----------------------------------------------------------- ------------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- -------------------------------------------------------
No consideration paid 340,000 RADSUs (representing 2,720,000 Ordinary Shares)
----------------------------------------------------------- --------------------- -------------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ------------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ------------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ------------------------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
-------------------------------------------------------------------------------------------------------------------------------------------
a) Name Kathleen Rickard
----------------------------------------------------------- ------------------------------------------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------------------------------------------------------
a) Position/status Chief Medical Officer
----------------------------------------------------------- ------------------------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ------------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ------------------------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ------------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-------------------------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Restricted American Depositary Share Units (RADSUs)
over American Depositary Shares ("ADSs"), each ADS
representing 8 Ordinary Shares.
Identification code ADS ISIN Code: US9250501064
----------------------------------------------------------- ------------------------------------------------------------------------------
b) Nature of the transaction Grant of RADSUs, each of which represents an unfunded,
unsecured right to receive, on the applicable settlement
date, one ADS or an amount in cash or other consideration.
----------------------------------------------------------- ------------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------------------------------- --------------------- -------------------------------------------------------
No consideration paid 383,395 RADSUs (representing 3,067,160 Ordinary Shares)
----------------------------------------------------------- --------------------- -------------------------------------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ------------------------------------------------------------------------------
e) Date of the transaction 20 August 2020
----------------------------------------------------------- ------------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------------------------- ------------------------------------------------------------------------------
(END) Dow Jones Newswires
August 26, 2020 05:19 ET (09:19 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Verona Pharma (LSE:VRP)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Verona Pharma (LSE:VRP)
Gráfica de Acción Histórica
De May 2023 a May 2024
